Analyst Recommendations for AGAM, AMZN, AMTD, PFE, NOK

Bank of America Initiates AGA Medical Holdings (AGAM) With Buy

Bank of America (NYSE: BAC) initiated coverage on AGA Medical Holdings Inc (NASDAQ: AGAM) with a buy recommendation at $20.00. AGAM holds 70% market share in the devices used for treatment of structural heart defects. Bank of America’s buy recommendation is based on AGAM’s product pipeline, which it feels has not been considered by the current market price.

Bank of America Sets Price Objective For Amazon (AMZN) At $140

Bank of America has set PO for Amazon (NASDAQ: AMZN) at $140, which represents 25 times its 2010 estimated FCF, 2 times its 2010E sales and 40X 2010 adjusted P/E. Bank of America expects the stock to trade at a wide range of 25x-40x non-GAAP P/E, owing to the uncertainty on long-term operating margins.

Northland Securities Recommends Underperform For TD Ameritrade (AMTD)

Northland issued “underperform” recommendation for TD Ameritrade Holding Corp. (NASDAQ: AMTD), with no target price owing to low interest environment. Ameritrade’s risk has been rated as aggressive by Northland and is currently trading at $19.64, almost near its 52 week high of $20.23.

Barclays Retains Overweight Rating For Pfizer (PFE)

Barclays has retained its overweight rating and price target of $21 for Pfizer Inc. (NYSE: PFE), which is currently trading at $18.72. Pfizer has entered in to an agreement with Protalix, under which it will receive exclusive world rights (excluding Israel) for a drug developed by Protalix for Gaucher’s disease.

BMO Issues Underperform Rating For Nokia (NOK)

BMO issued a underperform Rating for Nokia (NYSE: NOK) which is currently trading at $13.41 with a price target of $12.00. The underperform rating for Nokia by BMO is attributed to its projected 180 basis point decline in handset market share, 8% y-o-y decline in average selling price and its projected 400 basis point decline in share of industry profits.